Journal Club: Underprescribing vs Underfilling in Oral Anticoagulation for SPAF

Jan 25, 2023 | Antithrombotics

1b) This is a #journalclub review of an excellent article published in late 2022 in J Manag Care Spec Pharm 🔓 https://t.co/nKfAvbrmNB.👏to @ihdezdelso et al for an insightful study on a topic only gaining in importance as the population ages....

MOA and Clinical Trial Data for Novel and Emerging Therapeutic Strategies for HCM: Can We Target Our Therapy?

Jan 16, 2023 | HCM

1b) Our expert (and returning @cardiomet_ce) author is Giuseppe Galati MD, MMSc in Heart Failure, FHFA, @GiuseppeGalati_ , Consultant #Cardiologist #HeartFailure & #Cardiomyopathies pic.twitter.com/W3CgRK0qAS— cardio-met (@cardiomet_CE) January 17, 2023 3) This...

Summary of Available Data on Specific DOAC Reversal and Nonspecific Factor Repletion in Patients with Anti-FXa-DOAC-Associated Hemorrhage

Jan 9, 2023 | Antithrombotics

2) This 🆓program is accredited for 0.5h CE/#CME for #physicians #physicianassociates #nurses #nurespractitioners #pharmacists and is supported by a grant from AstraZeneca. See statement of accreditation and faculty disclosures at https://t.co/gvXca4G9Xm.—...

The Sleeping Giant:  Type 2 Diabetes & Sleep Disorders

Jan 2, 2023 | CARDIORENAL

2) Our expert faculty is Dr Kevin Fernando @drkevinfernando, FRCGP FRCP Edin, FAcadMEd MSc Diabetes, GP with Specialist Interest in CVRM & Medical Education. See statement of accreditation and faculty disclosures at https://t.co/gvXca4G9Xm....

AHA2022 UPDATE: META-ANALYSIS INDICATES SGLT2i SHOULD BE FOUNDATIONAL THERAPY IN CKD

Dec 28, 2022 | CARDIORENAL

2) This work was presented by Will Herrington @willkidney, @The_MRC @Kidney_Research UK funded AssocProf @Oxford_NDPH and representing the contributions of 241 participating sites from 8 countries 🌎🌍. EMPA-KIDNEY was funded and sponsored by Boehringer...